Welcome to Protecting Your Nest with Dr. Tony Hampton. Dr. Paul E. Marik is the co-Founder of the Frontline Covid-19 Critical Care Alliance—an alliance of doctors and medical scientists from around the world. Dr. Marik is a pioneer in medical research and is a former professor. He is the second most published critical care specialist in the world. In today’s episode, we discuss his most recent publication which is an extensive review of the evidence on the use of repurposed medications for treating cancer. In this discussion, Drs. Tony and Paul talk about: (05:16) The importance of having no conflicts of interest in medical research (06:21) Why the risk of cancer is increasing in our modern world (07:48) Why cancer is NOT a genetic disease and why many tumors cannot be cured by chemo therapy (11:43) The role of the stem cell in the development of cancer (13:30) The conventional theory of cancer and why it is wrong (15:08) One of the most effective ways to kill cancer cells: starve them of glucose (21:14) How cancer cells proliferate in the body (24:44) The Metabolic versus the Genetic theory of cancer and why processed foods, sugary drinks, lack of exercise, and poor sleep are cancer promoters (27:47) A study finding that a group who took Vitamin D, Omega-3, and followed a home exercise routine reduced their risk of cancer by 60% (31:13) The value of various drugs for the treatment of cancer (34:34) The most effective interventions for fighting cancer (37:48) Why diet is SO important for avoiding cancer and why glucose is especially bad (40:51) The differences between chemo and repurposed drugs (48:29) Cancers which are curable with surgery (48:59) Concluding thoughts Thank you for listening to Protecting Your Nest. For additional resources and information, please see the links below.   Links:   Dr. Paul E. Marik: FLCCC Podcast Slides   Dr. Tony Hampton: Linktree Instagram Account LinkedIn Account Ritmos Negros Podcast Q Med Symposium for Metabolic Health Lectures How Waking Up Every Day at 4:30 Can Change Your Life